May 15, 2026
The medical device industry has always demanded both precision engineering and flawless packaging. Until now, those two worlds often required two different partners. That changes today.
Averra Holdings and Banner Capital are pleased to announce a partnership with ZIEN Medical Technologies forming a single, vertically integrated organization capable of taking a medical device concept from initial design all the way through manufacturing, packaging, sterilization, and regulatory approval.
Two Organizations, One Mission
Averra Packaging, founded in 1989, has spent more than three decades mastering medical device packaging. Specializing in thermoformed and flexible packaging, Averra brings full in-house design, prototyping, tooling, and production all built to meet sterile performance requirements.
ZIEN Medical Technologies, founded in 2009, is a vertically integrated contract design and manufacturing organization (CDMO) with deep expertise in product design and development, cost optimization, manufacturing, packaging, sterilization, and quality and regulatory services.
Together, under the Averra Holdings umbrella and backed by Banner Capital, the combined organization offers what the market has been asking for: a single, trusted partner for the entire device lifecycle.
What the Combined Organization Delivers
- Product Design & Development
- Contract Manufacturing
- Turnkey Sterile Packaging
- Sterilization Services
- Quality & Regulatory Support
- Cost Optimization
Why It Matters for Medical Device Companies
Building a medical device typically means managing a fragmented supply chain design firms, manufacturers, packaging specialists, sterilization vendors, and regulatory consultants operating in separate silos. Handoffs introduce risk. Timelines stretch. Costs compound.
The Averra + ZIEN combination directly addresses this challenge. For medtech innovators whether a startup racing toward first-in-human or an established OEM looking to streamline this partnership offers a level of integration that is rare in the industry.
With renewed national emphasis on domestic manufacturing, the combined platform also provides a U.S.-based, vertically integrated supply chain that reduces exposure and strengthens business continuity.
In Their Own Words
“The partnership with ZIEN demonstrates Averra’s commitment to the medical device space and supports our mission to be a full-service provider of products and services to the industry. The combination of Averra and ZIEN creates an enterprise that is greater than the sum of its parts.”
Jeremy Horton, President, Averra / ZIEN
“ZIEN is a fantastic complement to Averra Packaging. Their differentiated approach to design, manufacturing, and expedited product launches naturally positions them as the top choice for OEMs looking to get innovative products to market quickly, domestically or internationally. Their unique positioning alleviates the regulatory and quality burden on clients, reduces cost, and accelerates speed-to-market.”
Ron Labrum, Chairman, Averra Holdings | Former CEO, Cardinal Health & Hill-Rom
Looking Ahead
The medical device industry is at an inflection point. Demand for innovative devices continues to rise. Regulatory complexity is increasing. And the pressure to bring products to market faster and at lower cost has never been greater.
Averra Holdings is building the platform that meets this moment. With ZIEN now a division of Averra Holdings, clients gain access to a seamlessly integrated team that can accompany a product from concept to a sterile, validated, market-ready device all within a single relationship.